Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 692

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 692
---
 299) ( 305) ( 8,664)
Additions to non-current assets (other than financial instruments and deferred tax assets) 48,288 - 48,288 664 21 48,973
December 31, 2024
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
Oncology/Immunology
Marketed
R& D Products Subtotal Other Ventures Unallocated Total
(in US$ ’ 000)
Total assets 225,661 88,502 314,163 194,604 765,429 1,274,196
Property, plant and equipment 91,929 - 91,929 448 121 92,498
Right-of-use assets 1,845 - 1,845 1,615 1,037 4,497
Leasehold land 10,706 - 10,706 - - 10,706
Goodwill - - - 2,990 - 2,990
Investment in an equity investee - - - 77,765 - 77,765
Investment in equity security 5,000 - 5,000 - - 5,000
December 31, 2023
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
Oncology/Immunology
Marketed
R& D Products Subtotal Other Ventures Unallocated Total
(in US$ ’ 000)
Total assets 202,288 63,601 265,889 163,311 850,573 1,279,773
Property, plant and equipment 98,952 - 98,952 564 211 99,727
Right-of-use assets 4,005 - 4,005 366 294 4,665
Leasehold land 11,261 - 11,261 - - 11,261
Goodwill - - - 3,064 - 3,064
Other intangible asset - - - 21 - 21
Investment in an equity investee - - - 48,411 - 48,411
Unallocated expenses mainly represent corporate expenses which include corporate administrative costs, corporate employee benefit expenses and the relevant share-based compensation expenses, net of interest income. Unallocated assets mainly comprise cash and cash equivalents and short-term investments.

F-52

Table of Contents

(ii